Viewing Study NCT03873402


Ignite Creation Date: 2025-12-25 @ 4:01 AM
Ignite Modification Date: 2025-12-26 @ 2:54 AM
Study NCT ID: NCT03873402
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-12
First Post: 2019-03-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module